Narayana Hrudayalaya

Narayana Hrudayalaya

1,753.50
-23.60
(-1.33%)
ann
Q1 Quarterly Results are out. Check out the updated financials18 hours ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
Market Cap
35,834.70 Cr
EPS
38.90
PE Ratio
45.61
Dividend Yield
0.26 %
52 Week High
2,370.20
52 Week Low
1,238.10
PB Ratio
9.88
Debt to Equity
0.62
Sector
Hospitals
Analyst Rating and Forecast
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+33.33 %
+33.33 %
Forecast For
Actual

Company News

View All News
Caret
positive
Narayana Health delivered consolidated operating revenue of ₹16,438 Mn in Q2FY26, marking 20.3% YoY growth, with EBITDA rising 28.3% to ₹4,265 Mn at 25.9% margin. The healthcare provider achieved highest-ever revenue and profitability at both India and Group levels, driven by strong domestic footfall growth and improved payor mix across its network of 18 hospitals and 2 heart centers.
positive
Narayana Hrudayalaya has completed the full acquisition of Practice Plus Group Hospitals in the United Kingdom. This transaction represents the healthcare company's expansion into the UK hospital market through the complete takeover of the Practice Plus Group's hospital operations.
positive
Narayana Hrudayalaya has acquired UK-based Practice Plus Group Hospitals for £183 million, marking the company's entry into the UK healthcare market. The acquisition includes NHS contracts and an asset-light day-care model with 50% available capacity. The company plans to scale operations and enhance private-pay presence using its digital Athma platform for efficiency and growth.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,103.10
#1 1,07,247.40
93.34
7,184.10
#1 28.65
1,076
#1 74.34
37.61
7,420.50
1,06,695.40
61.70
#1 21,994.30
14.76
#1 1,505
24.84
32.30
937.70
70,792.40
68.17
7,849.70
13.25
809
70.27
30.01
1,753.50
#4 35,834.70
#1 45.61
#4 5,575.00
#10 12.29
#4 790
#3 30.03
45.38
678.10
35,133.80
96.29
4,286.70
15.12
337
14.65
48.34
1,174.90
31,580.20
56.27
3,771.40
12.59
481
21.10
31.53
665.00
26,609.20
74.81
3,067.00
21.98
415
-40.35
34.47
1,341.50
13,624.20
52.75
1,566.90
17.46
244
-4.30
41.48
739.85
10,431.90
253.48
2,257.70
17.03
49
0.00
53.38
1,464.10
9,599.50
48.26
1,290.20
17.77
194
11.00
37.65

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
12.29 %
Net Income Growth
0.48 %
Cash Flow Change
-7.58 %
ROE
-20.08 %
ROCE
-17.99 %
EBITDA Margin (Avg.)
-0.28 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
365
378
409
400
432
455
492
459
489
526
565
558
653
655
714
735
776
782
829
791
750
398
611
755
846
867
952
967
951
1,041
1,173
1,140
1,236
1,249
1,324
1,222
1,273
1,331
1,424
1,353
1,503
1,532
1,668
Expenses
326
344
360
358
392
402
426
406
425
473
502
502
597
607
640
657
676
675
702
684
659
486
575
648
698
728
774
787
768
842
898
874
946
963
997
925
955
1,004
1,092
1,028
1,126
1,171
1,243
EBITDA
39
34
49
42
40
54
66
53
64
53
63
56
56
49
74
79
101
107
127
107
92
-87
36
107
148
139
179
180
182
200
275
266
290
286
327
297
318
327
332
325
377
361
425
Operating Profit %
10 %
8 %
11 %
10 %
8 %
11 %
13 %
11 %
12 %
9 %
10 %
9 %
8 %
7 %
10 %
10 %
12 %
13 %
15 %
13 %
11 %
-23 %
4 %
14 %
17 %
15 %
18 %
18 %
18 %
19 %
21 %
23 %
23 %
22 %
24 %
23 %
23 %
23 %
22 %
23 %
24 %
22 %
24 %
Depreciation
19
18
18
19
21
19
20
20
21
22
29
24
26
33
34
35
36
41
43
46
55
46
46
47
45
45
46
46
47
48
49
57
56
59
55
63
65
61
65
70
83
84
88
Interest
12
9
8
6
6
6
5
6
6
10
8
8
21
17
18
18
18
22
22
21
21
20
19
19
18
17
17
16
16
15
15
19
21
21
23
25
28
34
35
37
41
45
42
Profit Before Tax
10
10
26
20
13
29
41
28
37
21
26
24
9
-1
22
26
47
43
62
40
16
-153
-30
42
85
77
116
117
119
137
211
190
214
206
248
209
225
231
232
219
254
232
296
Tax
11
11
16
14
8
12
15
11
15
10
10
10
-1
3
8
13
10
13
17
9
4
-34
-26
1
17
1
17
20
50
27
42
36
40
22
22
21
34
30
33
26
57
35
37
Net Profit
-1
-1
10
6
5
17
27
17
22
11
17
14
10
-4
14
13
37
30
45
31
12
-120
-3
41
68
76
99
98
69
111
169
154
173
184
227
188
191
202
199
193
197
197
259
EPS in ₹
0.00
-0.03
0.52
0.29
0.25
0.85
1.31
0.84
1.10
0.54
0.82
0.70
0.48
-0.21
0.67
0.63
1.83
1.49
2.23
1.55
0.59
-5.90
-0.17
2.01
3.35
3.75
4.89
4.80
3.40
5.45
8.31
7.57
8.53
9.06
11.16
9.26
9.39
9.92
9.78
9.50
9.71
9.68
12.72

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
7,265
Fixed Assets
913
1,055
1,082
1,848
1,838
2,092
1,961
1,980
2,336
2,651
4,266
Current Assets
260
286
302
479
527
586
665
909
1,294
1,946
2,550
Capital Work in Progress
20
14
53
35
56
12
20
67
259
514
86
Investments
0
87
96
9
17
86
120
132
252
844
1,084
Other Assets
437
401
416
644
725
701
669
951
1,315
1,615
1,829
Total Liabilities
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
7,265
Current Liabilities
343
315
323
510
510
602
703
780
987
1,110
1,193
Non Current Liabilities
258
365
361
989
1,045
1,153
946
861
1,042
1,629
2,444
Total Equity
769
876
963
1,036
1,082
1,137
1,121
1,489
2,132
2,885
3,628
Reserve & Surplus
568
674
761
833
878
933
917
1,286
1,928
2,681
3,423
Share Capital
200
204
204
204
204
204
204
204
204
204
204

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-6
42
28
-22
89
8
-2
59
-4
97
205
Investing Activities
-223
-150
-146
-520
-162
-189
-113
-267
-1,176
-1,458
-1,325
Operating Activities
77
174
219
182
279
443
304
485
1,085
1,067
986
Financing Activities
140
18
-45
315
-27
-247
-194
-159
88
489
544

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
11.60 %
0.00 %
10.91 %
10.01 %
9.68 %
9.44 %
9.66 %
10.46 %
10.49 %
DIIs
14.80 %
15.55 %
16.15 %
14.61 %
13.76 %
13.43 %
16.18 %
14.58 %
14.14 %
11.95 %
10.89 %
9.46 %
9.51 %
8.23 %
7.90 %
8.69 %
8.52 %
8.09 %
7.76 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
4.64 %
4.97 %
4.85 %
5.11 %
5.92 %
6.87 %
5.86 %
6.93 %
7.10 %
7.99 %
8.46 %
9.04 %
10.00 %
11.68 %
12.13 %
11.58 %
11.47 %
11.18 %
11.45 %
Others
16.71 %
15.63 %
15.14 %
16.43 %
16.46 %
15.85 %
14.11 %
14.64 %
14.90 %
16.20 %
5.20 %
17.65 %
5.73 %
6.23 %
6.43 %
6.43 %
6.50 %
6.42 %
6.45 %
No of Share Holders
0
36,360
44,526
43,565
43,807
52,747
65,173
68,130
75,370
86,631
1,02,994
1,20,506
1,38,052
1,60,686
1,78,356
1,77,792
1,85,787
2,05,639
2,26,480

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 1 1 0.00 1 2.5 4 4.5
Dividend Yield (%) 0.00 0.00 0.00 0.4 0.25 0.00 0.13 0.19 0.24 0.26

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 Aug 2022 DIVIDEND Dividend
₹ 1.00 /share
22 Aug 2022 659.80 705.15
07 Jul 2023 DIVIDEND Dividend
₹ 2.50 /share
07 Jul 2023 767.85 1,012.95
02 Aug 2024 DIVIDEND Dividend
₹ 4.00 /share
02 Aug 2024 1,255.10 1,252.75
30 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Aug 2024 1,255.10 1,265.50
31 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Oct 2024 1,236.20 1,222.55
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 1,372.70 1,329.00
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 1,790.70 1,724.30
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
01 Aug 2025 1,991.45 1,916.05
01 Aug 2025 DIVIDEND Dividend
₹ 4.50 /share
01 Aug 2025 1,724.30 1,916.05
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2025 1,724.30 1,753.75
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2025 1,819.90 1,777.75

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release1 day ago
Announcement under Regulation 30 (LODR)-Investor Presentation1 day ago
Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 20251 day ago
Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 20251 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 20259 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome9 days ago
Announcement under Regulation 30 (LODR)-Updates on Acquisition9 days ago
Announcement under Regulation 30 (LODR)-Investor PresentationNov 03, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 31, 2025
Investor Presentation On The Acquisition Of UK-Based Practice Plus Group Hospitals LimitedOct 31, 2025
Announcement under Regulation 30 (LODR)-AcquisitionOct 30, 2025
Incorporation Of Wholly-Owned Overseas Step-Down SubsidiaryOct 08, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Announcement Under Regulation 30 - AcquisitionSep 13, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 21, 2025
Letter To Shareholders- Weblink Of 25Th AGM Notice And Annual Report For FY 2024-25Aug 18, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 07, 2025
Regulation 53 (1) Annual Report.Aug 07, 2025
Reg. 34 (1) Annual Report.Aug 07, 2025
Notice Of The 25Th Annual General Meeting (AGM) Of The Company For F.Y. 2024-25Aug 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 01, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 01, 2025
Recommendation By The Board For The Issuance Of Non-Convertible Securities.Aug 01, 2025
Board Meeting Outcome for Outcome Of The Board Meeting For The Unaudited Financial Results For The Quarter Ended June 30 2025 Aug 01, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025 Aug 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 29, 2025
Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2025 And Fund Raising.Jul 28, 2025
Communication To Shareholders - Intimation On Tax Deduction On DividendJul 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 27, 2025
Closure of Trading WindowJun 27, 2025
Rumour verification - Regulation 30(11)Jun 26, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 25, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 24, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Axis Small Cap Fund Direct-Growth
1.08%
-312169
-0.24%
-0.61%
Mirae Asset Midcap Fund Direct - Growth
0.73%
255915
0.23%
0.73%
Bandhan Small Cap Fund Direct-Growth
0.19%
190000
0.19%
0.19%
Nippon India Pharma Fund Direct-Growth
1.95%
-105304
-0.25%
-0.21%
Taurus Ethical Fund Direct-Growth
0.00%
-53965
-2.80%
-3.20%
UTI Multi Asset Allocation Fund Direct-Growth
0.07%
-51039
-0.15%
-0.11%
Taurus Flexi Cap Fund Direct - Growth
2.63%
31855
1.51%
1.49%
Mirae Asset Small Cap Fund Direct-Growth
1.97%
30000
-0.02%
0.05%
Capitalmind Flexi Cap Fund Direct - Growth
2.49%
26308
2.49%
2.49%
Samco Special Opportunities Fund Direct - Growth
0.00%
-23214
-2.51%
-2.51%
Shriram Multi Asset Allocation Fund Direct - Growth
0.42%
-3070
-0.40%
-0.42%
Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund Direct-Growth
1.04%
2570
-0.05%
-0.06%
Groww ELSS Tax Saver Fund Direct - Growth
0.00%
-2102
-0.71%
-0.72%
Nippon India Nifty 500 Momentum 50 Index Fund Direct-Growth
0.94%
1530
-0.04%
-0.06%
Shriram Balanced Advantage Fund Direct - Growth
0.09%
-1280
-0.39%
-0.38%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.58%
1279
-0.01%
-0.05%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.58%
1223
-0.01%
-0.05%
Sundaram Multi-Factor Fund Direct-Growth
1.27%
1162
-0.04%
-0.08%
Axis Nifty Smallcap 50 Index Fund Direct-Growth
1.55%
1017
-0.01%
1.55%
Quantum ESG Best In Class Strategy Fund Direct - Growth
1.05%
608
0.14%
0.14%
Shriram Aggressive Hybrid Fund Direct -Growth
0.35%
-540
-0.21%
-0.22%
Quantum Ethical Fund Direct - Growth
1.23%
472
0.03%
0.04%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.58%
401
-0.01%
-0.05%
Motilal Oswal Nifty 500 Momentum 50 Index Fund Direct-Growth
0.94%
350
-0.04%
-0.06%
Kotak Nifty Alpha 50 Index Fund Direct-Growth
2.18%
320
-0.05%
0.49%

Technical Indicators

RSI(14)
Neutral
45.38
ATR(14)
Less Volatile
45.18
STOCH(9,6)
Neutral
35.56
STOCH RSI(14)
Oversold
18.47
MACD(12,26)
Bearish
-2.95
ADX(14)
Weak Trend
12.09
UO(9)
Bearish
43.13
ROC(12)
Downtrend And Accelerating
-1.27
WillR(14)
Neutral
-79.56

About Narayana Hrudayalaya

Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years, 10 days)
Chairperson NameDEVI PRASAD SHETTY